Výsledky vyhledávání

Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study

Autor: F. Terhegggen, G. P. Bootsma, Hans M. Westgeest, Jessica S.W. Borgers, Daphne W. Dumoulin, M. Cloos, J. W. G. van Putten, John B. A. G. Haanen, C. J. van Loenhout, W. K. de Jong, I. Houtenbos, G. A. Cirkel, Otto Visser, J. C. Drooger, R. A.W. van de Wetering, T. J.N. Hiltermann, B. van den Borne, F. S. van der Meer, V. J.A.A. Nuij, Esther Oomen-de Hoop, C. H. van der Leest, Hanneke W. M. van Laarhoven, A. Becker-Commissaris, S. C.van t. Westeinde, A. P. Hamberg, L. van Leeuwen, A. S.R. van Lindert, B. W. Bouter, Rutger H. T. Koornstra, F. J. Borm, C. H. Rikers, E. A. Kastelijn, B. M.J. Scholtes, Y. Klaver, E. J.M. Siemerink, D. M. van Diepen, A. L. Peerdeman, Mieke J. Aarts, K. H. Herbschleb, V. E.M. van den Boogaart, Karijn P M Suijkerbuijk, G. Douma, S. D. Bakker, Karlijn de Joode, A. J. Staal, M. P.L. Bard, J. A. Stigt, C. C.M. Pitz, L. J. C. van Warmerdam, E. Looysen, Laurens V. Beerepoot, P. Brocken, C. R. van Rooijen, N. J.M. Claessens, Haiko J. Bloemendal, A.J. van de Wouw, Astrid A M van der Veldt, E. Citgez, Franchette W P J van den Berkmortel, M. Youssef, E. J. Geraedts, Nico G.J. van Diemen, G. L. Veurink, E. J. Libourel, N. P. Barlo, Elisabeth G.E. de Vries, J.W.B. de Groot, Anne-Marie C. Dingemans, W. H. van Geffen, G. J.M. Herder, Pim G N J Mutsaers, L. Strobbe, Jolien Tol, R. Heller, L. M. Faber, B. Franken, Lizza E.L. Hendriks, Mathilde Jalving, O. C.J. Schuurbiers-Siebers, B. C.M. Haberkorn, M. A. Tiemessen, M. Slingerland

Publikováno v: European Journal of Cancer
European Journal of Cancer, 141, pp. 171-184
European Journal of Cancer, 141, 171-184
European Journal of Cancer, 141, 171-184. Elsevier Limited
European Journal of Cancer, 141, 171-184. ELSEVIER SCI LTD
European Journal of Cancer, 141, 171-184. Elsevier Ltd.

Aim of the study Patients with cancer might have an increased risk for severe outcome of coronavirus disease 2019 (COVID-19). To identify risk factors associated with a worse outcome of COVID-19, a nationwide registry was developed for patients with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ab8641c47fce20aca6e3c9edc471009
http://www.scopus.com/inward/record.url?scp=85095410706&partnerID=8YFLogxK

Zobrazit plný text záznamu

Lipegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in Dutch patients

Autor: J N H, Timmer-Bonte, J, Ouwerkerk, L M, Faber, L G M, Kerkhofs, L, Laterveer, D, Ten Oever, B P, van Rees, P W, van der Linden

Publikováno v: The Netherlands journal of medicine. 78(5)

Chemotherapy (CT)-induced neutropenia and febrile neutropenia (FN) can lead to changes in the treatment plan, potentially worsening the cancer outcome. This study evaluated the effect of the glycopegylated granulocyte-colony stimulating factor lipegf

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0497dd84eaafee0a0847b72aa68e5b95
https://pubmed.ncbi.nlm.nih.gov/33093252

Zobrazit plný text záznamu

Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity

Autor: S.A.P. van Luxemburg-Heijs, J.H.F. Falkenburg, L. M. Faber, W. F. J. Veenhof, R. Willemze

Publikováno v: Blood. 86:2821-2828

HLA-identical bone marrow transplantation (BMT) is associated with both graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) reactivity. Different T-cell subsets from the bone marrow (BM) graft may be responsible for GVHD and GVL reactivi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a2b0a1327dc885df1e55ec0bedbbba4a
https://doi.org/10.1182/blood.v86.7.2821.2821

Zobrazit plný text záznamu

Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes

Autor: Els Goulmy, J.H.F. Falkenburg, L. M. Faber, S. A. P. van Luxemburg-Heijs, A. Hooftman-den Otter, J. van der Hoeven, R. Willemze

Publikováno v: J. Clin. Invest.

We investigated whether minor histocompatibility (mH) antigen-specific cytotoxic T lymphocytes (CTL) can discriminate between leukemic hematopoietic progenitor cells (leukemic-HPC) from AML or CML patients, the HPC from their remission bone marrow (r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8094490722de5be5e22bf96248ef1280
https://doi.org/10.1172/jci118134

Zobrazit plný text záznamu

Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes

Autor: Anneke Brand, W. E. Fibbe, S.A.P. van Luxemburg-Heijs, R. Willemze, L. M. Faber, J.H.F. Falkenburg, Y. M. C. Kooy-Winkelaar, J de Kroon, H. M. Goselink, D. Van Der Harst

Publikováno v: J. Exp. Med.
The Journal of Experimental Medicine

Minor histocompatibility (mH) antigens appear to play a major role in bone marrow transplantation (BMT) using HLA-identical donors. Previously, we reported the isolation of major histocompatibility complex (MHC)-restricted mH antigen-specific cytotox

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bccd7ca8fafcedc21b8ea2068327be87
https://doi.org/10.1084/jem.174.1.27

Zobrazit plný text záznamu

Two Dutch families with hereditary hyperferritinaemia-cataract syndrome and heterozygosity for an HFE-related haemochromatosis gene mutation

Autor: S, Simsek, P W B, Nanayakkara, J M F, Keek, L M, Faber, K F, Bruin, G, Pals

Publikováno v: The Netherlands journal of medicine. 61(9)

Hereditary haemochromatosis is an autosomal recessive disorder, leading to progressive iron overload, which is very common among the Caucasian population. In the vast majority of the cases, the hereditary iron overload is caused by mutations in the H

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c77ede40f77db37fa2e9e694d7a3c0aa
https://pubmed.ncbi.nlm.nih.gov/14692443

Zobrazit plný text záznamu

[Diagnosis and treatment of non-Hodgkin lymphoma in Netherlands: variation in guidelines and in practice]

Autor: L M, Faber, M, van Agthoven, C A, Uyl-de Groot, B, Löwenberg, P C, Huijgens

Publikováno v: Nederlands tijdschrift voor geneeskunde. 144(25)

To investigate current guidelines for diagnosis and treatment of intermediate or high grade non-Hodgkin's lymphoma (NHL), stage I-IV (Burkitt's and lymphoblastic lymphoma excluded) and to compare this with current clinical practice.Descriptive.An inv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3bd29fe36b688dbdcbb92e1588c156fa
https://pubmed.ncbi.nlm.nih.gov/10992902

Zobrazit plný text záznamu

Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon

Autor: L M, Faber, S A, van Luxemburg-Heijs, M, Rijnbeek, R, Willemze, J H, Falkenburg

Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2(1)

At present, allogeneic bone marrow transplantation (BMT) is the only curative treatment for chronic myeloid leukemia (CML) in chronic phase (CP). The graft-vs.-leukemia (GVL) effect appears to play an important role in this treatment. Direct evidence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8839658252cfff3471ab8a746aa85b71
https://pubmed.ncbi.nlm.nih.gov/9078352

Zobrazit plný text záznamu

Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia

Autor: R. Willemze, S.A.P. van Luxemburg-Heijs, L. M. Faber, J.H.F. Falkenburg

Publikováno v: The Journal of Experimental Medicine

Allogeneic bone marrow transplantation (BMT) has been associated with a graft-vs.-leukemia (GVL) reactivity. Since T cell depletion of the bone marrow graft has decreased the risk of graft-vs.-host disease (GVHD), but has been associated with higher

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe4a2188780aaf48a687df4cf5af9615
https://pubmed.ncbi.nlm.nih.gov/1402674

Zobrazit plný text záznamu

Citrate haemodialysis

Autor: L M, Faber, P M, de Vries, P L, Oe, J, van der Meulen, A J, Donker

Publikováno v: The Netherlands journal of medicine. 37(5-6)

We describe our experience with sodium citrate as anticoagulant in the haemodialysis of 15 patients who were at high risk for bleeding. Furthermore, in six of these patients who were on prolonged citrate dialysis, the last month of heparin dialysis w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::924856d4d25107f9bc84121e2406e28f
https://pubmed.ncbi.nlm.nih.gov/2074914

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání